RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Pain
Accession: DOID:9000641
browse the term
Definition: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
Synonyms: exact_synonym: Ache; Burning Pain; Crushing Pain; Crushing Pains; Migratory Pain; Migratory Pains; Physical Suffering; Physical Sufferings; Radiating Pain; Radiating Pains; aches; burning pains; splitting pain; splitting pains
primary_id: MESH:D010146
xref: EFO:0003843
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28193520
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Ace
angiotensin I converting enzyme
IMP
RGD
PMID:18555989
RGD:2325233
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adm
adrenomedullin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043245
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Aif1
allograft inflammatory factor 1
IEP
associated with Diabetes Mellitus, Experimental; protein:increased expression:spinal cord dorsal horn (rat)
RGD
PMID:18186080
RGD:2313034
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17084039
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:4126124
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:19580807
RGD:2317533
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Aqp1
aquaporin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20018876
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2271928 PMID:6094376
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
Bdkrb1
bradykinin receptor B1
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20152050 PMID:17988733
RGD:5129214
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20152050
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Bdnf
brain-derived neurotrophic factor
IEP
RGD
PMID:20452292
RGD:4891137
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17088553
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
G
Casp1
caspase 1
IMP
RGD
PMID:19853379
RGD:2315887
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Cck
cholecystokinin
IDA
RGD
PMID:17157334
RGD:2313635
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Cckbr
cholecystokinin B receptor
IMP
associated with Diabetes Mellitus, Experimental
RGD
PMID:16527403
RGD:2311323
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
G
Ccl2
C-C motif chemokine ligand 2
IDA
RGD
PMID:18419759
RGD:2307043
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl22
C-C motif chemokine ligand 22
IMP
RGD
PMID:11438578
RGD:2306307
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl5
C-C motif chemokine ligand 5
IMP
RGD
PMID:11438578
RGD:2306307
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr2
C-C motif chemokine receptor 2
IMP ISO
associated with Osteoarthritis, Knee;
RGD
PMID:18419759 PMID:23185004
RGD:2307043 , RGD:8661785
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Clcn7
chloride voltage-gated channel 7
IEP
mRNA:increased expression:spinal cord dorsal horn
RGD
PMID:11846422
RGD:1600865
NCBI chr10:14,151,758...14,177,130
Ensembl chr10:14,151,758...14,177,130
G
Cnr1
cannabinoid receptor 1
IMP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:19193902 PMID:19661434
RGD:2314649
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cnr2
cannabinoid receptor 2
IMP
RGD
PMID:19409856
RGD:2316193
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
G
Comt
catechol-O-methyltransferase
severity
IMP ISO
associated with Multiple Sclerosis;DNA:polymorphism:cds:rs4680(p.V158M)(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20561508 PMID:17084978 PMID:24290452
RGD:2289747 , RGD:13450948
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Crh
corticotropin releasing hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16495007
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Csf2
colony stimulating factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8622042
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7541186 PMID:8622042 PMID:10864982
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IMP
associated with Bone Neoplasms
RGD
PMID:20736819
RGD:4892020
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl12
C-X-C motif chemokine ligand 12
IMP
RGD
PMID:11438578
RGD:2306307
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Disc1
DISC1 scaffold protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20561508
NCBI chr19:53,014,201...53,223,617
Ensembl chr19:53,014,616...53,219,778
G
Drd2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15996639
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19429182 PMID:20042899
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Gch1
GTP cyclohydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19081190
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gjb1
gap junction protein, beta 1
ISO
ClinVar Annotator: match by term: Pain
ClinVar
PMID:16096811 PMID:21291455 PMID:22243284 PMID:25388846 PMID:25741868 PMID:26467025 PMID:28448691 PMID:28492532 More...
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Gla
galactosidase, alpha
treatment
IMP
Allyl isothiocyanate (XCO:0000608) compared to wild type
RGD
PMID:29563343 PMID:29563343
RGD:150429980 , RGD:150429980
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
G
Glaem2Mcwi
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin
IMP
compared to wild type
RGD
PMID:29563343
RGD:150429980
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18155693
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Hcrt
hypocretin neuropeptide precursor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16202530
NCBI chr10:85,689,979...85,691,214
Ensembl chr10:85,689,465...85,691,210
G
Hfe
homeostatic iron regulator
ISO
ClinVar Annotator: match by term: Pain
ClinVar
PMID:678784 PMID:8696333 PMID:8896549 PMID:8896550 PMID:8931958 PMID:9024376 PMID:9138148 PMID:9162021 PMID:9211748 PMID:9321765 PMID:9326341 PMID:9328324 PMID:9341868 PMID:9356458 PMID:9439654 PMID:9462220 PMID:9482831 PMID:9585606 PMID:9851896 PMID:9851897 PMID:10381492 PMID:10401000 PMID:10431233 PMID:10575540 PMID:11040194 PMID:11532995 PMID:11812557 PMID:11903354 PMID:12241803 PMID:12429850 PMID:12436244 PMID:12542741 PMID:12693884 PMID:12707220 PMID:12915468 PMID:14618419 PMID:14729817 PMID:15060098 PMID:15070663 PMID:15254010 PMID:15280838 PMID:15347835 PMID:15858186 PMID:16132052 PMID:16879202 PMID:17389307 PMID:17450498 PMID:17828789 PMID:18199861 PMID:18499578 PMID:18504828 PMID:18566337 PMID:19084217 PMID:19159930 PMID:19429178 PMID:19444013 PMID:19554541 PMID:20301613 PMID:20471131 PMID:21243428 PMID:22531912 PMID:23178241 PMID:23953397 PMID:24033266 PMID:24604426 PMID:25457201 PMID:25728773 PMID:25741868 PMID:25741869 PMID:25850353 PMID:26153218 PMID:26365338 PMID:27124787 PMID:27518069 PMID:27659401 PMID:27890643 PMID:28492532 PMID:31061747 PMID:31335359 PMID:31436889 PMID:31980526 PMID:32153640 PMID:37260121 More...
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26000320
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hoxd1
homeo box D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21151121
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Hrh1
histamine receptor H 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12128009 PMID:14569158
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12595749 PMID:21945716
RGD:5683627
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
IDA
RGD
PMID:16165284
RGD:1626470
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Htr2c
5-hydroxytryptamine receptor 2C
IDA
RGD
PMID:17451674
RGD:1624996
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Htr3b
5-hydroxytryptamine receptor 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17600820
NCBI chr 8:49,279,291...49,308,444
Ensembl chr 8:49,279,173...49,308,444
G
Htr7
5-hydroxytryptamine receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17600820
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Il18
interleukin 18
IDA
RGD
PMID:19853379
RGD:2315887
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15317861
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12421473
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
RGD
PMID:20626857
RGD:5509945
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1281941 PMID:3951883 PMID:10445233 PMID:10543429 PMID:16076651 PMID:20018876 PMID:29655911 More...
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Map2k2
mitogen activated protein kinase kinase 2
ISO
ClinVar Annotator: match by term: Pain
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Ngf
nerve growth factor
treatment
IMP ISO
associated with Cystitis, Interstitial
RGD
PMID:19103210 PMID:17905097
RGD:2303798 , RGD:7242806
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
IMP
associated with Inflammation
RGD
PMID:20060234
RGD:5144063
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nos3
nitric oxide synthase 3
IMP
RGD
PMID:18079061
RGD:2292111
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nppa
natriuretic peptide A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:13679232
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27687165
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Npr1
natriuretic peptide receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27687165
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
G
Nrg1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20561508
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Ntsr1
neurotensin receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20727387
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
G
Oprd1
opioid receptor, delta 1
IDA
RGD
PMID:12710986
RGD:2316589
NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9463367
NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
IDA
RGD
PMID:12710986
RGD:2316589
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Oxt
oxytocin/neurophysin I prepropeptide
IMP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:6094376 PMID:17420069 PMID:17664006
RGD:2304129
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Pdyn
prodynorphin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17670969 PMID:20068450
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15833551
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Plcb1
phospholipase C beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16405873
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
G
Pnoc
prepronociceptin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19231294
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
G
Pomc
proopiomelanocortin
ISO IMP
CTD Direct Evidence: marker/mechanism|therapeutic associated with Inflammation
CTD RGD
PMID:4345333 PMID:6094376 PMID:20084599 PMID:17223201
RGD:407574731
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Pparg
peroxisome proliferator-activated receptor gamma
IMP
RGD
PMID:18387855
RGD:2301890
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
treatment
IDA
RGD
PMID:20359166
RGD:10002735
NCBI chr 4:32,970,501...33,292,360
Ensembl chr 4:33,024,450...33,286,907
G
Prkg1
protein kinase cGMP-dependent 1
IEP
protein:increased expression:spinal cord
RGD
PMID:12384231
RGD:7775057
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Prokr1
prokineticin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16793879
NCBI chr 4:120,022,301...120,033,367
Ensembl chr 4:120,021,747...120,033,379
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IEP IMP
associated with Osteoarthritis, Knee;mRNA, protein:increased expression:spinal cord
RGD
PMID:18637715 PMID:17942724
RGD:2300223 , RGD:2300252
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
susceptibility
IMP ISO IEP
associated with lung neoplasm;DNA:SNP:exon:rs5275 (human) associated with Osteoarthritis, Knee;mRNA, protein:increased expression:spinal cord
RGD
PMID:18497304 PMID:19773451 PMID:18637715
RGD:2300228 , RGD:5135482 , RGD:2300223
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptn
pleiotrophin
severity
ISO
RGD
PMID:20826137
RGD:10043829
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
G
Slc6a1
solute carrier family 6 member 1
ISO
RGD
PMID:17918738
RGD:1643217
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
G
Slc9a1
solute carrier family 9 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19248819
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Tac1
tachykinin, precursor 1
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7694222 PMID:10445233 PMID:17493276
RGD:2304337
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tacr1
tachykinin receptor 1
IMP
RGD
PMID:18407414
RGD:2304276
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
G
Tacr3
tachykinin receptor 3
IMP
RGD
PMID:19093101
RGD:2304256
NCBI chr 2:223,266,536...223,363,791
Ensembl chr 2:223,266,536...223,363,791
G
Tjp1
tight junction protein 1
IEP
associated with Inflammation;protein:increased expression:brain
RGD
PMID:19319146
RGD:2325136
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr2
toll-like receptor 2
IDA
RGD
PMID:24204973
RGD:8553185
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IMP
RGD
PMID:18662331
RGD:2312574
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18582539 PMID:20383154
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
protein:increased expression:dorsal root ganglion (rat)
RGD
PMID:21248590
RGD:5130897
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Trh
thyrotropin releasing hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:6409194
NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20601631
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16996476 PMID:17575321 PMID:20422007 PMID:23006841
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Vip
vasoactive intestinal peptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9920454
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Hfe
homeostatic iron regulator
ISO
ClinVar Annotator: match by term: Abdominal pain
ClinVar
PMID:678784 PMID:8696333 PMID:8896549 PMID:8896550 PMID:8931958 PMID:9024376 PMID:9138148 PMID:9162021 PMID:9211748 PMID:9321765 PMID:9326341 PMID:9328324 PMID:9341868 PMID:9356458 PMID:9439654 PMID:9462220 PMID:9482831 PMID:9585606 PMID:9851896 PMID:9851897 PMID:10381492 PMID:10401000 PMID:10431233 PMID:10575540 PMID:11040194 PMID:11532995 PMID:11812557 PMID:11903354 PMID:12241803 PMID:12429850 PMID:12436244 PMID:12542741 PMID:12693884 PMID:12707220 PMID:12915468 PMID:14618419 PMID:14729817 PMID:15060098 PMID:15070663 PMID:15254010 PMID:15280838 PMID:15347835 PMID:15858186 PMID:16132052 PMID:16879202 PMID:17389307 PMID:17450498 PMID:17828789 PMID:18199861 PMID:18499578 PMID:18504828 PMID:18566337 PMID:19084217 PMID:19159930 PMID:19429178 PMID:19444013 PMID:19554541 PMID:20301613 PMID:20471131 PMID:21243428 PMID:22531912 PMID:23178241 PMID:23953397 PMID:24033266 PMID:24604426 PMID:25457201 PMID:25728773 PMID:25741868 PMID:25741869 PMID:25850353 PMID:26153218 PMID:26365338 PMID:27124787 PMID:27518069 PMID:27659401 PMID:27890643 PMID:28492532 PMID:31061747 PMID:31335359 PMID:31436889 PMID:31980526 PMID:32153640 PMID:37260121 More...
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hmbs
hydroxymethylbilane synthase
ISO
ClinVar Annotator: match by term: Abdominal pain
ClinVar
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
IDA
RGD
PMID:24291101
RGD:10043376
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Comt
catechol-O-methyltransferase
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:polymorphism:cds:p.V158M(human)
RGD
PMID:25102390
RGD:13450943
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Septin9
septin 9
ISO
ClinVar Annotator: match by term: Amyotrophic neuralgia | ClinVar Annotator: match by term: Amyotrophy, hereditary neuralgic | ClinVar Annotator: match by term: Hereditary Neuralgic Amyotrophy (HNA)
ClinVar
PMID:16186812 PMID:17546647 PMID:18492087 PMID:19139049 PMID:19204161 PMID:19451530 PMID:20019224 PMID:20301569 PMID:22981636 PMID:25741868 PMID:26467025 PMID:28492532 PMID:28503616 PMID:31619932 More...
NCBI chr10:102,409,798...102,579,056
Ensembl chr10:102,409,711...102,579,055
G
Adrb1
adrenoceptor beta 1
ISO
RGD
PMID:11527135
RGD:5129114
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
ISO
RGD
PMID:11527135
RGD:5129114
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11128043 PMID:11791009
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
Cpb2
carboxypeptidase B2
ISO
RGD
PMID:12624641
RGD:1598479
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
G
Mir146a
microRNA 146a
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1730212
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Ppbp
pro-platelet basic protein
ISO
protein:increased expression:plasma
RGD
PMID:17045893
RGD:401794448
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:16421174
RGD:1581390
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7543699
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Mvk
mevalonate kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10369261
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
G
Tsc2
TSC complex subunit 2
ISO
ClinVar Annotator: match by term: Arthralgia
ClinVar
PMID:25741868 PMID:28492532 PMID:30311386
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
G
Wnt10a
Wnt family member 10A
ISO
ClinVar Annotator: match by term: Arthralgias
ClinVar
PMID:24449199 PMID:28492532
NCBI chr 9:76,349,931...76,362,400
Ensembl chr 9:76,349,931...76,362,400
G
Htr2a
5-hydroxytryptamine receptor 2A
IDA
RGD
PMID:17268262
RGD:1624379
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12227717
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Cxcr4
C-X-C motif chemokine receptor 4
IEP IMP
mRNA,protein:increased expression:spinal cord:
RGD
PMID:28108674 PMID:28638088
RGD:13463594 , RGD:13838657
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Dlg4
discs large MAGUK scaffold protein 4
ameliorates
IMP
RGD
PMID:26738857
RGD:243048441
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
G
Jak2
Janus kinase 2
treatment
IEP
RGD
PMID:30027795
RGD:149735350
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Mir338
microRNA 338
IEP
RNA:decreased expression:spinal cord:
RGD
PMID:28108674
RGD:13463594
NCBI chr10:105,297,923...105,297,988
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
IEP
mRNA, protein:increased expression:spinal cord (rat)
RGD
PMID:25919859
RGD:152025537
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Robo1
roundabout guidance receptor 1
exacerbates
IMP
RGD
PMID:26738857
RGD:243048441
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
G
Slit2
slit guidance ligand 2
ameliorates
IMP
RGD
PMID:26738857
RGD:243048441
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Crh
corticotropin releasing hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2563132
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Myh6
myosin heavy chain 6
ISO
ClinVar Annotator: match by term: Chest pain
ClinVar
PMID:25741868 PMID:27600940 PMID:28492532
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
G
Myh7
myosin heavy chain 7
ISO
ClinVar Annotator: match by term: Chest pain
ClinVar
PMID:7731997 PMID:7796500 PMID:8483915 PMID:8541871 PMID:8951566 PMID:9172070 PMID:9742054 PMID:9835779 PMID:10024460 PMID:10725281 PMID:12974739 PMID:16650083 PMID:17125710 PMID:17192269 PMID:17703256 PMID:19150014 PMID:20031618 PMID:21310275 PMID:21674835 PMID:22429680 PMID:22765922 PMID:23074333 PMID:23283745 PMID:23816408 PMID:24033266 PMID:24111713 PMID:24714796 PMID:24793961 PMID:25132132 PMID:25351510 PMID:25611685 PMID:25741868 PMID:27247418 PMID:27532257 PMID:27885498 PMID:28408708 PMID:28492532 PMID:28615295 PMID:28790153 PMID:29300372 PMID:29875424 PMID:30847666 PMID:31447099 PMID:31513939 PMID:31737537 PMID:32746448 PMID:32894683 PMID:33029862 PMID:33087929 PMID:33673806 PMID:34067482 PMID:35288587 More...
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
G
Bdnf
brain-derived neurotrophic factor
IEP
protein:increased expression:frontal cortex, neuron mRNA:decreased expression:anterior cingulate cortex
RGD
PMID:11360665 PMID:24518228
RGD:5684922 , RGD:10059366
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Cpt2
carnitine palmitoyltransferase 2
ISO
ClinVar Annotator: match by term: Chronic pain
ClinVar
PMID:7711730 PMID:9600456 PMID:10090476 PMID:12410208 PMID:12673791 PMID:12707442 PMID:15622536 PMID:16996287 PMID:17936304 PMID:20301431 PMID:22975760 PMID:25741868 PMID:28492532 PMID:34063237 More...
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Hfe
homeostatic iron regulator
ISO
DNA:missense mutation: :p.C282Y (rs1800562) (human)
RGD
PMID:30657865
RGD:14746966
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IEP
protein:increased expression:frontal cortex, neuron
RGD
PMID:11360665
RGD:5684922
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Scn9a
sodium voltage-gated channel alpha subunit 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21634377
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:24204973
RGD:8553185
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:24204973
RGD:8553185
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10440088
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
severity
ISO
DNA:polymorphism:cds:p.Arg296Cys(human)
RGD
PMID:11055624
RGD:401901272
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Dnmt3b
DNA methyltransferase 3 beta
ISO
protein:increased expression:ectopic endometrium:
RGD
PMID:22572543
RGD:9588664
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Gstm1
glutathione S-transferase mu 1
severity
ISO
DNA:deletion,polymorphism::
RGD
PMID:11055624
RGD:401901272
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Oxt
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10440088
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Dmd
dystrophin
ISO
ClinVar Annotator: match by term: Exertional myalgia, muscle stiffness and myoglobinuria
ClinVar
PMID:19367636 PMID:21104870 PMID:25637381 PMID:25741868 PMID:26066469 PMID:26365249 PMID:26467025 PMID:28492532 PMID:31648988 PMID:33644936 PMID:35135626 PMID:36409343 More...
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:4327920
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
ISO
ClinVar Annotator: match by term: Familial episodic pain syndrome 1 | ClinVar Annotator: match by term: TRPA1-related condition
OMIM ClinVar
PMID:20547126 PMID:25741868 PMID:36430572
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Scn10a
sodium voltage-gated channel alpha subunit 10
ISO
ClinVar Annotator: match by term: Episodic pain syndrome, familial, 2
OMIM ClinVar
PMID:9536098 PMID:17576681 PMID:23115331 PMID:24820863 PMID:24998131 PMID:25053638 PMID:25085921 PMID:25691538 PMID:25691686 PMID:25741868 PMID:25842276 PMID:26220970 PMID:26423924 PMID:26733327 PMID:27711072 PMID:28074886 PMID:28078312 PMID:28106320 PMID:28166811 PMID:28407228 PMID:28492532 PMID:29247119 PMID:29874177 PMID:29911575 PMID:30135145 PMID:30403391 PMID:30554136 PMID:30662450 PMID:30821013 PMID:31195250 PMID:31780880 PMID:31928344 PMID:32581362 PMID:32917565 PMID:32948286 More...
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
G
Scn11a
sodium voltage-gated channel alpha subunit 11
ISO ISS
ClinVar Annotator: match by term: Episodic pain syndrome, familial, 3 OMIM:615552
OMIM ClinVar MouseDO
PMID:9536098 PMID:17576681 PMID:24207120 PMID:24776970 PMID:25741868 PMID:25791876 PMID:27224030 PMID:27503742 PMID:28298626 PMID:28492532 PMID:30046661 PMID:30554136 PMID:30557356 More...
NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10864982
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Fkrp
fukutin related protein
ISO
ClinVar Annotator: match by term: Headache
ClinVar
PMID:11741828 PMID:12666124 PMID:14647208 PMID:15060126 PMID:15574464 PMID:15580560 PMID:15833432 PMID:15883334 PMID:15886712 PMID:16344347 PMID:16634037 PMID:16786213 PMID:17554798 PMID:18060779 PMID:18593008 PMID:18639457 PMID:19705481 PMID:19820980 PMID:19835634 PMID:19900540 PMID:20961759 PMID:21220724 PMID:21228398 PMID:22264518 PMID:22981120 PMID:23576288 PMID:23591631 PMID:24447024 PMID:25048216 PMID:25560911 PMID:25741868 PMID:26363967 PMID:26467025 PMID:26574668 PMID:26833294 PMID:28112097 PMID:28479227 PMID:28492532 PMID:30232282 PMID:30564623 PMID:30919934 PMID:31268217 PMID:32914449 PMID:34008892 PMID:34653404 More...
NCBI chr 1:77,479,641...77,486,954
Ensembl chr 1:77,476,084...77,486,992
G
Gnrh1
gonadotropin releasing hormone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12910066
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7537110
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Npc1
NPC intracellular cholesterol transporter 1
ISO
ClinVar Annotator: match by term: Headache
ClinVar
PMID:10521290 PMID:11333381 PMID:11349231 PMID:11479732 PMID:11754101 PMID:12401890 PMID:12955717 PMID:14639697 PMID:15937921 PMID:16098014 PMID:20301473 PMID:20554533 PMID:23183285 PMID:23427322 PMID:23773996 PMID:23791518 PMID:25236789 PMID:25349751 PMID:25425405 PMID:25741868 PMID:26666848 PMID:26981555 PMID:28492532 PMID:32138288 PMID:32248828 More...
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
G
Oxt
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7080326
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
human protein in rat model
RGD
PMID:21036476
RGD:5131274
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Wfs1
wolframin ER transmembrane glycoprotein
ISO
DNA:missense mutation: :p.H611R (human)
RGD
PMID:17719176
RGD:8694403
NCBI chr14:73,810,478...73,834,993
Ensembl chr14:73,810,404...73,835,602
G
Abat
4-aminobutyrate aminotransferase
treatment
IMP
RGD
PMID:24890317
RGD:9588557
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
G
Adk
adenosine kinase
IMP
associated with diabetic neuropathies;
RGD
PMID:11423084 PMID:9932716
RGD:6482662 , RGD:6482666
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Adm
adrenomedullin
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17043245 PMID:17043245
RGD:1625316
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adora1
adenosine A1 receptor
IDA
associated with Spinal Cord Injuries
RGD
PMID:20065990
RGD:5129094
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adra1a
adrenoceptor alpha 1A
IEP
associated with Diabetes Mellitus, Experimental; mRNA:increased expression:dorsal root ganglion
RGD
PMID:10841349
RGD:5688377
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Adra2a
adrenoceptor alpha 2A
IMP
RGD
PMID:17959985
RGD:6480488
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Adra2c
adrenoceptor alpha 2C
IMP
RGD
PMID:20007733
RGD:6893568
NCBI chr14:75,470,884...75,472,846
Ensembl chr14:75,471,143...75,472,846
G
Adrb1
adrenoceptor beta 1
IMP
RGD
PMID:19283893
RGD:5129125
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Ager
advanced glycosylation end product-specific receptor
treatment
IMP ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25014009 PMID:25014009 PMID:24077211
RGD:8695980 , RGD:7364865
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9613798
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Aif1
allograft inflammatory factor 1
IEP ISO
associated with Alcohol-Induced Disorders, Nervous System; protein:increased expression:spinal cord (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27093858 PMID:17284346
RGD:2313035
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akr1b1
aldo-keto reductase family 1 member B1
IDA
associated with Hyperglycemia
RGD
PMID:12505670
RGD:1626082
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Alox12
arachidonate 12-lipoxygenase, 12S type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12582831
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12582831
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Ano3
anoctamin 3
IMP
RGD
PMID:23872594
RGD:9681745
NCBI chr 3:97,235,671...97,550,090
Ensembl chr 3:97,238,354...97,550,154
G
Anxa1
annexin A1
IMP IEP
protein:increased expression:dorsal root ganglion
RGD
PMID:9222544 PMID:21990306
RGD:2306950 , RGD:7421656
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Aqp4
aquaporin 4
IEP
associated with Spinal Cord Injuries;mRNA,protein:increased expression:brain,spinal cord:
RGD
PMID:16219025
RGD:8695957
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9613798
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
Bace1
beta-secretase 1
IMP
RGD
PMID:28012171
RGD:13782150
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Bdkrb1
bradykinin receptor B1
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17989505 PMID:19300402 PMID:19815945 PMID:12927641 PMID:12637034
RGD:1579989 , RGD:7241581
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
IMP ISO
CTD Direct Evidence: marker/mechanism associated with Diabetic Neuropathy
CTD RGD
PMID:17989505 PMID:19300402 PMID:19815945 PMID:10188975 PMID:19300402
RGD:4891040 , RGD:2313332
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Bdnf
brain-derived neurotrophic factor
IMP IEP IDA ISO
associated with Peripheral Nerve Injuries; associated with inflammation;protein:increased expression:dorsal root ganglion: associated with Sciatic Neuropathy; associated with Pancreatitis, Chronic;
RGD
PMID:11425916 PMID:21958434 PMID:10779676 PMID:12435470 PMID:21864655 PMID:21499209 PMID:12470870 More...
RGD:8657088 , RGD:8657122 , RGD:8657114 , RGD:8657101 , RGD:8657099 , RGD:8657093 , RGD:8657091
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
IEP
RGD
PMID:23665054
RGD:11560531
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
C3
complement C3
IEP
associated with Sciatic Neuropathy;mRNA, protein:increased expression:spinal cord
RGD
PMID:23588254
RGD:7401259
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
IDA
RGD
PMID:17567797
RGD:1626313
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19577366 PMID:30552955 PMID:34286406
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cacna1i
calcium voltage-gated channel subunit alpha1 I
IMP
RGD
PMID:17112407
RGD:15003199
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11245671 PMID:17881535 PMID:24133248
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
G
Calca
calcitonin-related polypeptide alpha
IEP ISO
associated with inflammation;protein:increased expression:dorsal root ganglion: CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:12787826 PMID:12855330 PMID:15265675 PMID:27093858 PMID:21958434
RGD:8657122
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20053885 PMID:18042863
RGD:7240711
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Capn2
calpain 2
treatment
IMP
associated with Peripheral Nerve Injuries
RGD
PMID:25150005
RGD:13792585
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Cartpt
CART prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21167239
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
G
Cat
catalase
treatment
IEP IMP
RGD
PMID:23952340 PMID:23658840
RGD:9479063 , RGD:9479069
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cck
cholecystokinin
IDA
RGD
PMID:15647484
RGD:1626108
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Cckbr
cholecystokinin B receptor
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11880531 PMID:15647484
RGD:1626108
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
G
Ccl2
C-C motif chemokine ligand 2
IDA ISO IEP IMP
CTD Direct Evidence: marker/mechanism protein:increased expression:dorsal root ganglion, spinal cord (rat)
CTD RGD
PMID:17881535 PMID:18419759 PMID:21712071 PMID:20737477 PMID:22531750
RGD:2307043 , RGD:8548873 , RGD:8548848 , RGD:8548845
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
IEP IDA
mRNA:increased expression:dorsal root ganglion (rat)
RGD
PMID:18076762 PMID:18656466
RGD:4890034 , RGD:2303121
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr2
C-C motif chemokine receptor 2
IMP ISO IEP
associated with Intervertebral disc disease; associated with Demyelinating Diseases; associated with Sciatic Neuropathy; protein:increased expression:dorsal horn of spinal cord: associated with Bone Neoplasms;protein:increased expression:spinal cord:
RGD
PMID:18419759 PMID:24462503 PMID:18076762 PMID:24907405 PMID:22721162 PMID:23511129 More...
RGD:2307043 , RGD:8661788 , RGD:4890034 , RGD:8661781 , RGD:8548831 , RGD:8661772
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
IEP ISO IMP
mRNA:increased expression:dorsal root ganglion (rat) associated with Spinal Cord Injuries
RGD
PMID:18076762 PMID:22033364 PMID:23147416 PMID:24589480
RGD:4890034 , RGD:8551820 , RGD:8551809 , RGD:8551795
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cfl1
cofilin 1
IEP
protein:increased phosphorylation:dorsal root ganglion (rat)
RGD
PMID:24962708
RGD:11570412
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
ameliorates
IMP
RGD
PMID:15652389
RGD:150530460
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ameliorates
IDA
associated with sciatic neuropathy;
RGD
PMID:20619541
RGD:151708701
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17572696
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cnr2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:17572696 PMID:18664590
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
G
Comt
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28195063 PMID:20726980
RGD:8662326
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Crcp
CGRP receptor component
IEP
RGD
PMID:12895509
RGD:727768
NCBI chr12:26,623,968...26,659,756
Ensembl chr12:26,623,976...26,768,225
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28434951
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Csf3
colony stimulating factor 3
treatment
ISO
associated with Sciatic Neuropathy;
RGD
PMID:24253780
RGD:11039470
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csk
C-terminal Src kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16769263
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
G
Ctss
cathepsin S
IMP ISO
associated with Arthritis, Experimental associated with Colitis
RGD
PMID:22213084 PMID:21802389
RGD:5686870 , RGD:5686873
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cx3cl1
C-X3-C motif chemokine ligand 1
treatment
IDA IEP
associated with Arthritis, Experimental
RGD
PMID:19249394 PMID:22647647
RGD:2304251 , RGD:9491779
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO IEP IMP
associated with Arthritis, Experimental;protein:increased expression:lumbar spinal cord associated with Inflammation associated with Sciatic Neuropathy associated with Bone Neoplasms
RGD
PMID:20609517 PMID:22647647 PMID:16324111 PMID:20524966 PMID:19959384 PMID:20736819 More...
RGD:4891885 , RGD:9491779 , RGD:9387859 , RGD:9354422 , RGD:4891942 , RGD:4892020
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl12
C-X-C motif chemokine ligand 12
IDA
RGD
PMID:28638088
RGD:13838657
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcr2
C-X-C motif chemokine receptor 2
IMP
RGD
PMID:19283893
RGD:5129125
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
treatment
IMP
RGD
PMID:28638088 PMID:30142543
RGD:13838657 , RGD:13838658
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cybb
cytochrome b-245 beta chain
ISO
associated with Spinal Cord Injuries;
RGD
PMID:20679217
RGD:11040629
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Dlg4
discs large MAGUK scaffold protein 4
IDA
associated with Diabetic neuropathies;
RGD
PMID:20531396
RGD:7257680
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
G
Drd3
dopamine receptor D3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20433900
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Dusp1
dual specificity phosphatase 1
treatment
IEP IDA
associated with Sciatic Neuropathy
RGD
PMID:22901764 PMID:22540262
RGD:7771531 , RGD:7771574
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
treatment
IEP
associated with Sciatic Neuropathy
RGD
PMID:22901764
RGD:7771531
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Edn1
endothelin 1
susceptibility
ISO
mRNA:increased expression:paw skin (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19429182 PMID:23347081 PMID:15664691
RGD:8661716 , RGD:8661735
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
treatment
IMP
RGD
PMID:20392816
RGD:9685429
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Ep300
E1A binding protein p300
IMP
RGD
PMID:25263804
RGD:9588307
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epha4
Eph receptor A4
IMP
associated with spinal cord injuries;
RGD
PMID:16959251
RGD:5688783
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
G
Ephx2
epoxide hydrolase 2
IMP
RGD
PMID:16962614
RGD:5688387
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Erbb4
erb-b2 receptor tyrosine kinase 4
IEP
associated with interstitial cystitis;
RGD
PMID:30989724
RGD:405295490
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Esr1
estrogen receptor 1
ISO
RGD
PMID:19285805
RGD:8553066
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
IDA ISO
RGD
PMID:17056036 PMID:19285805
RGD:5508846 , RGD:8553066
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
associated with Sciatic Neuropathy
RGD
PMID:16251448
RGD:7387272
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F2r
coagulation factor II (thrombin) receptor
severity
ISO IDA
RGD
PMID:19674841 PMID:11877315 PMID:12717003
RGD:7387269 , RGD:7387271 , RGD:7387270
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
Fcgr1a
Fc gamma receptor 1A
ameliorates
IMP
RGD
PMID:32510872
RGD:127338469
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP ISO
protein:increased expression:dorsal horn of spinal cord, neuron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27093858 PMID:22160634
RGD:9999169
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
treatment
ISO
associated with Cerebral Hemorrhage
RGD
PMID:34102854
RGD:329812008
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
G
Gad1
glutamate decarboxylase 1
treatment
ISO IEP
protein:increased expression:dorsal horn of spinal cord
RGD
PMID:26752351 PMID:27277808
RGD:405850208 , RGD:405850240
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gal
galanin and GMAP prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12787826
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Gdnf
glial cell derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20457222
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
G
Gfap
glial fibrillary acidic protein
IEP ISO
associated with Spinal Cord Injuries;mRNA,protein:increased expression:brain,spinal cord: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27093858 PMID:16219025
RGD:8695957
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gfra1
GDNF family receptor alpha 1
IDA
RGD
PMID:16464682
RGD:6218969
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Gja1
gap junction protein, alpha 1
treatment
IMP ISO IEP
associated with Sciatic Neuropathy CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:34286406 PMID:24631560 PMID:23374942
RGD:8662447 , RGD:8662456
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gper1
G protein-coupled estrogen receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25280432
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
treatment
ISO
RGD
PMID:27816787
RGD:405650587
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
IDA
RGD
PMID:29758384
RGD:13792698
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20042082 PMID:24204988
RGD:13210755
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Grk2
G protein-coupled receptor kinase 2
treatment severity
IDA IMP IEP
associated with bone cancer associated with Complex Regional Pain Syndromes
RGD
PMID:26935064 PMID:22796071 PMID:25466829 PMID:26064176
RGD:13513996 , RGD:13792780 , RGD:13514049 , RGD:13514046
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Grm8
glutamate metabotropic receptor 8
ISO
RGD
PMID:17113112
RGD:6771186
NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
associated with Limb Ischemia;protein:increased expression:foot muscle, plantar
RGD
PMID:18691814
RGD:9068903
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IEP IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27474498 PMID:24077211 PMID:30142543
RGD:7364865 , RGD:13838658
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hoxd1
homeo box D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21151121
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Htr2a
5-hydroxytryptamine receptor 2A
IDA IMP ISO
associated with Diabetic neuropathies; CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17888573 PMID:18930597 PMID:20531396 PMID:25584948 PMID:20039957
RGD:7257680 , RGD:401938625 , RGD:401901200
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr7
5-hydroxytryptamine receptor 7
IMP IDA
RGD
PMID:21693130 PMID:21843960
RGD:6480665 , RGD:6482179
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9452187
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
treatment
IEP ISO IDA
associated with Sciatic Neuropathy CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:7582491 PMID:17174526 PMID:23957449 PMID:24077211 PMID:22820166
RGD:7364792 , RGD:7364865 , RGD:7364827
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
treatment
ISO
RGD
PMID:11399514
RGD:8549555
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il17a
interleukin 17A
treatment
IDA IMP
RGD
PMID:23192794 PMID:23246025
RGD:9068942 , RGD:9222699
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
treatment
IMP
associated with Peripheral Nerve Injuries
RGD
PMID:19036970
RGD:8655929
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12727271
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
IDA ISO
CTD Direct Evidence: marker/mechanism associated with Peripheral Nerve Injuries
CTD RGD
PMID:7582491 PMID:10401557 PMID:12727271 PMID:17320857 PMID:20937348 PMID:27093858 PMID:15317861 PMID:8741165 PMID:23159984 PMID:22265659 More...
RGD:1626676 , RGD:7401209 , RGD:7175548 , RGD:6482671
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
IMP ISO
RGD
PMID:19022353 PMID:11585580
RGD:8662898 , RGD:8662903
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il1rn
interleukin 1 receptor antagonist
severity treatment
IDA ISO IMP
CTD Direct Evidence: marker/mechanism|therapeutic associated with Arthritis, Experimental; rat model treated with human protein
CTD RGD
PMID:8864563 PMID:15317861 PMID:17174526 PMID:20937348 PMID:23092240 PMID:10903985 PMID:17959986 PMID:22933159 More...
RGD:6909165 , RGD:8549800 , RGD:7401210 , RGD:6909175
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
treatment
IMP IDA IEP
associated with Sciatic Neuropathy; mRNA,protein:increased expression:spinal cord:
RGD
PMID:12755376 PMID:18423867 PMID:22189457
RGD:8662973 , RGD:8662980 , RGD:8662977
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il33
interleukin 33
IMP
RGD
PMID:29329586
RGD:40400909
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il6
interleukin 6
IEP ISO
associated with Foot Injuries; protein:increased expression:serum: CTD Direct Evidence: marker/mechanism mRNA:increased expression:dorsal root ganglion
CTD RGD
PMID:7582491 PMID:10401557 PMID:18652822 PMID:18988309 PMID:23953943
RGD:8662979 , RGD:10402830
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
IEP
mRNA:increased expression:dorsal root ganglion
RGD
PMID:23953943
RGD:10402830
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Insr
insulin receptor
treatment
ISO
associated with Diabetic Neuropathies CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18331706 PMID:23511693
RGD:10403050
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
G
Itga1
integrin subunit alpha 1
IMP
knock-down using a specific monoclonal antibody or RNAi PGE2-induced
RGD
PMID:15836982 PMID:14984413
RGD:2302139 , RGD:2302389
NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:46,653,193...46,812,238
G
Itga2
integrin subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18234883
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga3
integrin subunit alpha 3
IMP
knock-down using a specific monoclonal antibody or RNAi
RGD
PMID:14984413 PMID:15836982
RGD:2302389 , RGD:2302139
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itga5
integrin subunit alpha 5
IMP
epinephrine-induced knock-down using a specific monoclonal antibody or RNAi
RGD
PMID:14984413 PMID:15836982
RGD:2302389 , RGD:2302139
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
G
Itgb1
integrin subunit beta 1
IMP
knock-down using a specific monoclonal antibody or RNAi
RGD
PMID:14984413 PMID:15836982
RGD:2302389 , RGD:2302139
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
IEP
RGD
PMID:25972297
RGD:13793383
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Jak2
Janus kinase 2
treatment
IMP ISO
associated with Diabetic Neuropathies
RGD
PMID:18636982 PMID:23511693
RGD:6483031 , RGD:10403050
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jak3
Janus kinase 3
treatment
IEP
RGD
PMID:21434883
RGD:11533942
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Kcnc4
potassium voltage-gated channel subfamily C member 4
IMP
RGD
PMID:17855600
RGD:10411908
NCBI chr 2:195,063,967...195,100,244
Ensembl chr 2:195,071,769...195,099,233
G
Kcnk2
potassium two pore domain channel subfamily K member 2
ISO
RGD
PMID:16675954
RGD:9831112
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcnq3
potassium voltage-gated channel subfamily Q member 3
IEP
associated with Bone Neoplasms;protein:decreased expression:dorsal root ganglia (rat)
RGD
PMID:23352759
RGD:9686417
NCBI chr 7:97,730,219...98,025,652
Ensembl chr 7:97,730,465...98,025,653
G
Kmo
kynurenine 3-monooxygenase
treatment
IMP
RGD
PMID:26524415
RGD:13703043
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2010815 PMID:2128375 PMID:3061568 PMID:7493622 PMID:7582491 PMID:7881729 PMID:9714424 PMID:9720808 PMID:10401557 PMID:10499367 PMID:10543429 PMID:15626726 PMID:16259764 PMID:16793879 PMID:18234883 PMID:21521205 More...
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Kng2
kininogen 2
IDA
RGD
PMID:20868656
RGD:11059894
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29143802
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
IEP
RGD
PMID:23665054
RGD:11560531
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map2k3
mitogen activated protein kinase kinase 3
onset
ISO
RGD
PMID:19427893
RGD:7495807
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12941468 PMID:27093858
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12941468 PMID:27093858
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk7
mitogen-activated protein kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17237256
NCBI chr10:46,170,264...46,176,262
Ensembl chr10:46,170,167...46,176,267
G
Mapk8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mc1r
melanocortin 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19996949
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mc4r
melanocortin 4 receptor
IEP
protein:increased expression:dorsal root ganglia (rat)
RGD
PMID:20081244
RGD:6484233
NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719
G
Mecp2
methyl CpG binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010341
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Men1
menin 1
IEP
associated with Sciatic Neuropathy;protein:increased expression:spinal cord dorsal horn (rat)
RGD
PMID:20369282
RGD:9589142
NCBI chr 1:203,638,905...203,644,871
Ensembl chr 1:203,639,000...203,644,871
G
Mfn2
mitofusin 2
IEP ISO
mRNA:decreased expression:spinal cord (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28587902 PMID:28587902
RGD:12910704
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mir15b
microRNA 15b
IDA
RGD
PMID:28012171
RGD:13782150
NCBI chr 2:153,245,200...153,245,297
Ensembl chr 2:153,245,200...153,245,297
G
Mir17
microRNA 17
severity
IMP
RGD
PMID:26222740
RGD:11074685
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
G
Mir381
microRNA 381
treatment
IDA
RGD
PMID:30142543
RGD:13838658
NCBI chr 6:128,740,976...128,741,036
G
Mir500
microRNA 500
IEP
RNA:decreased expression:dorsal horn of spinal cord
RGD
PMID:27277808
RGD:405850240
NCBI chr X:15,258,778...15,258,857
Ensembl chr X:15,258,768...15,258,859
G
Mir96
microRNA 96
treatment
IDA
associated with Sciatic Neuropathy
RGD
PMID:24234845
RGD:11553932
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
G
Mmp3
matrix metallopeptidase 3
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18754875 PMID:22056600
RGD:8693664
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mpz
myelin protein zero
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16676325
NCBI chr13:83,570,811...83,576,680
Ensembl chr13:83,570,811...83,576,679
G
Mtor
mechanistic target of rapamycin kinase
IMP
RGD
PMID:24382350
RGD:10040983
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nectin1
nectin cell adhesion molecule 1
IMP
RGD
PMID:27394444
RGD:405866373
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
G
Nefh
neurofilament heavy chain
treatment
IEP
RGD
PMID:21071147
RGD:27226885
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Ngf
nerve growth factor
treatment
ISO IMP IDA
associated with Cystitis associated with Osteoarthritis, Experimental CTD Direct Evidence: marker/mechanism associated with Peripheral Nerve Injuries;
CTD RGD
PMID:20457222 PMID:16203088 PMID:27208420 PMID:24095693 PMID:11425916 PMID:22839415 PMID:18448607 More...
RGD:7242799 , RGD:405100717 , RGD:402463955 , RGD:8657088 , RGD:7242849 , RGD:7242803
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
treatment
IMP
associated with Brachial Plexus Neuropathies
RGD
PMID:23324933
RGD:10413898
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nlgn2
neuroligin 2
IMP
RGD
PMID:23891900
RGD:9831150
NCBI chr10:54,544,461...54,557,854
Ensembl chr10:54,544,588...54,558,434
G
Nos1
nitric oxide synthase 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19300402 PMID:23909597
RGD:7257597
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17989504 PMID:19300402
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npy
neuropeptide Y
treatment
IEP
associated with Sciatic Neuropathy
RGD
PMID:19556004
RGD:10448929
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nrg1
neuregulin 1
IEP
associated with Sciatic Neuropathy associated with interstitial cystitis;
RGD
PMID:22212401 PMID:30989724
RGD:10449019 , RGD:405295490
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Ntf3
neurotrophin 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659614
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
IMP
RGD
PMID:17667845 PMID:20351485
RGD:5144120 , RGD:5684352
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
ISO IEP
associated with inflammation;protein:increased expression:dorsal root ganglion:
RGD
PMID:12470870 PMID:21958434
RGD:8657091 , RGD:8657122
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Ntsr1
neurotensin receptor 1
IDA
RGD
PMID:22396077
RGD:9743902
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
G
Oprk1
opioid receptor, kappa 1
treatment
IMP
associated with Diabetes Mellitus, Experimental;
RGD
PMID:16924480
RGD:9834947
NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823
G
Oprl1
opioid related nociceptin receptor 1
IEP
associated with Sciatic Neuropathy;mRNA:increased expression:spinal cord lumbar segment,dorsal root ganglion:
RGD
PMID:12106803
RGD:9835017
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17996026
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
P2rx2
purinergic receptor P2X 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19383439
NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891
G
P2rx3
purinergic receptor P2X 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19383439
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
G
P2rx4
purinergic receptor P2X 4
treatment
IMP
associated with Peripheral Nerve Injuries;
RGD
PMID:29927790
RGD:40924654
NCBI chr12:33,844,609...33,862,265
Ensembl chr12:33,844,396...33,862,253
G
P2ry12
purinergic receptor P2Y12
ISO IMP
RGD
PMID:20398327 PMID:20136836
RGD:6480525 , RGD:6480526
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
G
Pawr
pro-apoptotic WT1 regulator
treatment
IDA
RGD
PMID:17179954
RGD:9835416
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pdyn
prodynorphin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17670969
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
treatment
ISO
associated with Diabetes Mellitus, Experimental;
RGD
PMID:23235561
RGD:10003116
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Pla2g4a
phospholipase A2 group 4A
IMP
RGD
PMID:16203828
RGD:1642461
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Pnoc
prepronociceptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12665541 PMID:19231294
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
G
Pomc
proopiomelanocortin
treatment
IMP
associated with Inflammation
RGD
PMID:19934807
RGD:407580522
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
IMP
RGD
PMID:26732138
RGD:11572421
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Prkcb
protein kinase C, beta
IDA
associated with inflammation;protein:increased activity:spinal cord
RGD
PMID:16360284
RGD:1625519
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkce
protein kinase C, epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11738263 PMID:12582831 PMID:20457222
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkcg
protein kinase C, gamma
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19955894 PMID:27093858 PMID:12560106
RGD:28867224
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
G
Prkcz
protein kinase C, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27899695
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Prkg1
protein kinase cGMP-dependent 1
treatment
ISO
RGD
PMID:14973199
RGD:7775058
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Prok2
prokineticin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16793879
NCBI chr 4:132,346,681...132,361,754
Ensembl chr 4:132,347,103...132,361,385
G
Prokr1
prokineticin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16793879
NCBI chr 4:120,022,301...120,033,367
Ensembl chr 4:120,021,747...120,033,379
G
Ptafr
platelet-activating factor receptor
treatment
IMP
RGD
PMID:16925995
RGD:10041052
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Ptger1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11375261
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
G
Ptger3
prostaglandin E receptor 3
IEP
protein:increased expression:lumbar spinal cord dorsal horn (rat)
RGD
PMID:17413918
RGD:5688169
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
G
Ptger4
prostaglandin E receptor 4
treatment
IMP
RGD
PMID:20423341
RGD:10003041
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptges3
prostaglandin E synthase 3
IMP
RGD
PMID:16192391
RGD:5688057
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IEP ISO
protein:increased expression:spinal cord CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17989504 PMID:17413918
RGD:5688169
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17112505 PMID:17989504 PMID:15464832
RGD:5688224
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pthlh
parathyroid hormone-like hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16769263
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18976650
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Rgs4
regulator of G-protein signaling 4
treatment
IMP
associated with lesion of sciatic nerve
RGD
PMID:27641322
RGD:13524513
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Scn10a
sodium voltage-gated channel alpha subunit 10
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16545521 PMID:19070548
RGD:6484253
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
G
Scn11a
sodium voltage-gated channel alpha subunit 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23264124
NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044
G
Sin3a
SIN3 transcription regulator family member A
IEP
associated with Arthritis, Experimental;mRNA:decreased expression:spinal cord, neuron
RGD
PMID:17553988
RGD:9495916
NCBI chr 8:57,481,539...57,536,195
Ensembl chr 8:57,481,573...57,536,192
G
Slc12a5
solute carrier family 12 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20086212
NCBI chr 3:153,696,517...153,735,801
Ensembl chr 3:153,696,517...153,735,765
G
Slc17a8
solute carrier family 17 member 8
IEP
protein:increased expression:dorsal horn of spinal cord, neuron
RGD
PMID:22160634
RGD:9999169
NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20714283
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IEP
protein:increased phosphorylation:spinal cord
RGD
PMID:27394444
RGD:405866373
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Stat3
signal transducer and activator of transcription 3
treatment
IMP
RGD
PMID:24098399
RGD:8694290
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Syn2
synapsin II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18701217
NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192
G
Tac1
tachykinin, precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8864563 PMID:9714424 PMID:10499367 PMID:12351280 PMID:12787826 PMID:15626726 PMID:16259764 PMID:18234883 PMID:19231294 More...
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15964684 PMID:17123731
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
G
Tcf7l2
transcription factor 7 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33607128
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
G
Tgfbr1
transforming growth factor, beta receptor 1
IMP
associated with Experimental Pancreatitis, Chronic
RGD
PMID:26645248
RGD:14995470
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Thbd
thrombomodulin
treatment
ISO
associated with Inflammation CTD Direct Evidence: therapeutic
CTD RGD
PMID:27474498 PMID:24004409
RGD:11038687
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tlr2
toll-like receptor 2
ISO IDA
RGD
PMID:17355971 PMID:24204973
RGD:8553059 , RGD:8553185
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IMP ISO
RGD
PMID:20714435 PMID:24204973 PMID:15809417
RGD:4144070 , RGD:8553185 , RGD:7815040
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
IMP ISO IDA IEP
CTD Direct Evidence: marker/mechanism associated with Diabetic Neuropathies; mRNA,protein:increased expression:spinal cord: protein:increased expression:lumbar vertebra:
CTD RGD
PMID:7582491 PMID:7881729 PMID:10401557 PMID:12727271 PMID:16472913 PMID:17320857 PMID:18463260 PMID:18582539 PMID:20383154 PMID:26141506 PMID:27093858 PMID:16675114 PMID:21104419 PMID:17304130 PMID:10825476 PMID:18790011 PMID:17459378 PMID:16675114 More...
RGD:7387300 , RGD:7401179 , RGD:7394757 , RGD:7394741 , RGD:7394737 , RGD:7387302 , RGD:7387300
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16769263
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IMP IEP ISO
associated with Sciatic Neuropathy
RGD
PMID:12752784 PMID:22652595 PMID:21712071 PMID:24257399 PMID:20417692 PMID:21145890 More...
RGD:5130913 , RGD:8661750 , RGD:8548873 , RGD:8661737 , RGD:8661726 , RGD:5130939
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO IMP
associated with Sciatic Neuropathy
RGD
PMID:18463260 PMID:22652595
RGD:5130960 , RGD:8661750
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
IMP ISO
associated with Peripheral Nerve Injuries; CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18234885 PMID:21481532 PMID:23523557 PMID:18954467
RGD:10043618
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Trpc1
transient receptor potential cation channel, subfamily C, member 1
IMP
associated with Inflammation
RGD
PMID:19439599
RGD:7247605
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
IMP
RGD
PMID:19439599
RGD:7247605
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
IEP ISO
associated with inflammation;protein:increased expression:dorsal root ganglion: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12151517 PMID:18234885 PMID:18774343 PMID:23006841 PMID:21958434
RGD:8657122
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18234883
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
G
Vip
vasoactive intestinal peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12787826
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Aqp4
aquaporin 4
ISO
RGD
PMID:20851747
RGD:8696005
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Hdac4
histone deacetylase 4
ISO
RGD
PMID:19672313
RGD:9681457
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Cebpe
CCAAT/enhancer binding protein epsilon
ISO
ClinVar Annotator: match by term: CEBPE-related condition | ClinVar Annotator: match by term: Pelger-Huet-like anomaly and episodic fever with abdominal pain
OMIM ClinVar
PMID:4831644 PMID:25741868 PMID:26104880 PMID:28492532 PMID:31201888
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
ISO
ClinVar Annotator: match by term: Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold | ClinVar Annotator: match by term: PPM1D-related condition
OMIM ClinVar
PMID:23907125 PMID:24262437 PMID:25741868 PMID:28343630 PMID:28492532 PMID:28852847 PMID:29752822 PMID:29758292 PMID:29758562 PMID:30216591 PMID:30388424 PMID:30795918 PMID:31916397 PMID:37183572 PMID:37378944 More...
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
G
Ace
angiotensin I converting enzyme
ISO
mRNA:increased expression:ventricular myocardium (human) mRNA:increased expression:myocardium
RGD
PMID:15131005 PMID:11451295
RGD:8142363 , RGD:8548894
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Agt
angiotensinogen
ISO
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
ISO
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Akt1
AKT serine/threonine kinase 1
ISO
protein:increased serine phosphorylation:platelet
RGD
PMID:20467748
RGD:5509094
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Apoa4
apolipoprotein A4
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:20367977
RGD:5685646
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Bdnf
brain-derived neurotrophic factor
ISO
RGD
PMID:16186425
RGD:4891111
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Crp
C-reactive protein
disease_progression
ISO
RGD
PMID:9761079
RGD:9491780
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Edn1
endothelin 1
ISO
associated with Coronary Artery Disease;protein:increased expression:coronary sinus, plasma (human)
RGD
PMID:14556009
RGD:8661755
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
F7
coagulation factor VII
ISO
protein:increased expression:plasma (human)
RGD
PMID:10653827
RGD:2312399
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:18333374
RGD:5508458
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Itga2
integrin subunit alpha 2
susceptibility
ISO
RGD
PMID:15104219
RGD:1582303
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itgam
integrin subunit alpha M
ameliorates
ISO
protein:decreased expression:neutrophil (human)
RGD
PMID:18043994
RGD:329901840
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
RGD
PMID:10486281
RGD:1582334
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
G
Mir126a
microRNA 126a
disease_progression
ISO
RGD
PMID:32595526
RGD:401851053
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
G
Mir21
microRNA 21
ISO
RNA:decreased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mmp1
matrix metallopeptidase 1
ISO
RGD
PMID:14675588
RGD:1582536
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Pappa
pappalysin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11586954
NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2382605
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pten
phosphatase and tensin homolog
ISO
RNA:increased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Selp
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21162967
RGD:6219003
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Serpinc1
serpin family C member 1
treatment
ISO
RGD
PMID:8122184
RGD:11035255
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:14592844
RGD:1580841
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Txn1
thioredoxin 1
ISO
RGD
PMID:15749180
RGD:1580784
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7888893
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20714283
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Bdkrb1
bradykinin receptor B1
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:17852785
RGD:4890450
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:17852785
RGD:4890450
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:transition:cds:g.677C>T (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17491230 PMID:17491230
RGD:4891159
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
protein:decreased expression:serum
RGD
PMID:15648548
RGD:1620974
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Comt
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25218601
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25218601
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Gch1
GTP cyclohydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25218601
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Lama2
laminin subunit alpha 2
ISO
ClinVar Annotator: match by term: Myalgia
ClinVar
PMID:9674786 PMID:18700894 PMID:25741868 PMID:28445022 PMID:28492532 PMID:30055037 PMID:32904964 More...
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
G
Ryr1
ryanodine receptor 1
ISO
ClinVar Annotator: match by term: Myalgia
ClinVar
PMID:24195946 PMID:25741868 PMID:28259615 PMID:28492532 PMID:33564012 PMID:34008892 More...
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
Slc12a3
solute carrier family 12 member 3
ISO
ClinVar Annotator: match by term: Myalgia
ClinVar
PMID:8528245 PMID:9734597 PMID:10988270 PMID:12039972 PMID:17329572 PMID:18391953 PMID:21415153 PMID:22009145 PMID:23328711 PMID:25741868 PMID:26467025 PMID:26921350 PMID:28492532 PMID:35591852 PMID:35628451 More...
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc2a1
solute carrier family 2 member 1
ISO
ClinVar Annotator: match by term: Myalgia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Mlip
muscular LMNA-interacting protein
ISO
ClinVar Annotator: match by term: Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis
OMIM ClinVar
PMID:34581780 PMID:34935254 PMID:35672413 PMID:35915960
NCBI chr 8:77,935,087...78,204,725
Ensembl chr 8:77,935,079...78,204,254
G
Dtna
dystrobrevin, alpha
ISO
ClinVar Annotator: match by term: MYOPATHY WITH MYALGIA, INCREASED SERUM CREATINE KINASE, AND WITH OR WITHOUT EPISODIC RHABDOMYOLYSIS 2
OMIM ClinVar
PMID:36799992
NCBI chr18:14,687,193...14,944,232
Ensembl chr18:14,587,852...14,944,261
G
Comt
catechol-O-methyltransferase
severity
ISO
associated with breast cancer;DNA:missense mutation:cds:p.V158M (human)
RGD
PMID:21898113
RGD:8662332
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Adra2a
adrenoceptor alpha 2A
IEP
RGD
PMID:12946573
RGD:6893571
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Adra2c
adrenoceptor alpha 2C
IEP
RGD
PMID:12946573
RGD:6893571
NCBI chr14:75,470,884...75,472,846
Ensembl chr14:75,471,143...75,472,846
G
Ager
advanced glycosylation end product-specific receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25014009
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Aqp9
aquaporin 9
ameliorates
IMP
RGD
PMID:31746418
RGD:152995474
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17442347 PMID:18400411 PMID:19339603 PMID:24133248
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
G
Cdk5
cyclin-dependent kinase 5
ameliorates
IMP
RGD
PMID:24659417
RGD:401940123
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cfl1
cofilin 1
treatment
IEP
associated with Sciatic Neuropathy
RGD
PMID:27216618
RGD:11568694
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Ctss
cathepsin S
IEP IMP
RGD
PMID:18700000 PMID:17551020
RGD:5686878 , RGD:5686911
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Ctsz
cathepsin Z
IEP
RGD
PMID:18700000
RGD:5686878
NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31432094
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17292584
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17720801
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Drd1
dopamine receptor D1
IEP
RGD
PMID:22171983
RGD:6907447
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
IMP IEP
RGD
PMID:22902996 PMID:22171983
RGD:6907443 , RGD:6907447
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Foxp3
forkhead box P3
treatment
IEP ISO
mRNA:increased expression: L4-L5 of the spinal cord
RGD
PMID:30858084 PMID:30858084
RGD:38599004 , RGD:38599004
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gal
galanin and GMAP prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18400411
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Gch1
GTP cyclohydrolase 1
treatment
IMP
RGD
PMID:19922668
RGD:401700384
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gfra1
GDNF family receptor alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18400411
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Gja1
gap junction protein, alpha 1
ISO
associated with Spinal Cord Injuries;
RGD
PMID:22951907
RGD:7364890
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
IEP
RGD
PMID:24659417
RGD:401940123
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grk1
G protein-coupled receptor kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31432094
NCBI chr16:76,122,501...76,135,792
Ensembl chr16:76,123,842...76,135,792
G
Grk2
G protein-coupled receptor kinase 2
treatment
IEP
RGD
PMID:24216329
RGD:13792703
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Grm5
glutamate metabotropic receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19840219
NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274
G
Hmgb1
high mobility group box 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25014009
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
protein:increased expression:dorsal raphe nucleus
RGD
PMID:31045847
RGD:405849276
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2c
5-hydroxytryptamine receptor 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28011743
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Il10
interleukin 10
treatment
IDA IMP ISO
RGD
PMID:16949747 PMID:25078297 PMID:24077211
RGD:1598632 , RGD:11049468 , RGD:7364865
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31432094
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Itgam
integrin subunit alpha M
IEP
mRNA:increased expression:lumbar vertebra
RGD
PMID:15145554
RGD:1342461
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Kdr
kinase insert domain receptor
IEP
RGD
PMID:20705122
RGD:5684389
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Mir135a
microRNA 135a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31432094
NCBI chr 7:26,611,990...26,612,089
Ensembl chr 7:26,611,990...26,612,089
G
Mir135b
microRNA 135b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31432094
NCBI chr13:43,638,857...43,638,953
Ensembl chr13:43,638,857...43,638,953
G
Mir154
microRNA 154
IMP
RGD
PMID:31746418
RGD:152995474
NCBI chr 6:128,752,947...128,753,030
Ensembl chr 6:128,752,947...128,753,030
G
Mir208a
microRNA 208a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31432094
NCBI chr15:28,425,570...28,425,652
G
Mir221
microRNA 221
treatment
IMP
RGD
PMID:27059231
RGD:151347419
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
G
Mir223
microRNA 223
treatment
IDA
RGD
PMID:28580822
RGD:25824768
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Nfatc1
nuclear factor of activated T-cells 1
IEP
RGD
PMID:23386250
RGD:329337338
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfatc4
nuclear factor of activated T-cells 4
treatment
IEP
RGD
PMID:23386250
RGD:329337338
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
G
Nos1
nitric oxide synthase 1
treatment
IDA
RGD
PMID:23342771
RGD:7257658
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18400411
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14718584 PMID:18400411
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
P2ry12
purinergic receptor P2Y12
IMP
RGD
PMID:20665560
RGD:6480524
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
G
Pomc
proopiomelanocortin
treatment
IMP
RGD
PMID:23624847
RGD:407574732
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Prkg1
protein kinase cGMP-dependent 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30152261
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Scn10a
sodium voltage-gated channel alpha subunit 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18400411
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
G
Scn9a
sodium voltage-gated channel alpha subunit 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19557861
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
G
Socs1
suppressor of cytokine signaling 1
treatment
IEP
RGD
PMID:27059231
RGD:151347419
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
treatment
IEP
RGD
PMID:33746000
RGD:150521727
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Tac1
tachykinin, precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18400411
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:24979268
RGD:11073677
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr4
toll-like receptor 4
IEP
mRNA:increased expression:lumbar vertebra
RGD
PMID:15145554
RGD:1342461
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20846523
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf8
TNF superfamily member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31432094
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP
RGD
PMID:21107265
RGD:405650611
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Grm8
glutamate metabotropic receptor 8
ISO
RGD
PMID:17113112
RGD:6771186
NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831
G
Pdyn
prodynorphin
IDA
RGD
PMID:25663984
RGD:401851903
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Pomc
proopiomelanocortin
ISO
RGD
PMID:21380811
RGD:5508807
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Ptger4
prostaglandin E receptor 4
IMP
RGD
PMID:21371033
RGD:6483537
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgis
prostaglandin I2 synthase
ameliorates
ISO
RGD
PMID:26611322
RGD:11536046
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Vip
vasoactive intestinal peptide
IDA
RGD
PMID:19467283
RGD:5685608
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Ccl2
C-C motif chemokine ligand 2
ISO IEP
protein:increased expression:medulla oblongata, dorsal horn of spinal cord (mouse) protein:increased expression:ipsilateral side, dorsal root ganglion (rat)
RGD
PMID:22721162 PMID:15041200
RGD:8548831 , RGD:8548884
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ep300
E1A binding protein p300
treatment
IMP IEP
mRNA:increased expression:lumbar spinal cord (rat)
RGD
PMID:23176208 PMID:23176208
RGD:7327202 , RGD:7327202
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Hmgb1
high mobility group box 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27474498
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Thbd
thrombomodulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27474498
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tlr4
toll-like receptor 4
treatment
ISO
RGD
PMID:18615568
RGD:7815041
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO IMP
protein:increased expression:Schwann cell
RGD
PMID:11376190 PMID:10825476 PMID:9514564 PMID:18394803
RGD:7394735 , RGD:7394741 , RGD:7394740 , RGD:7394739
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
ClinVar Annotator: match by term: Paroxysmal extreme pain disorder
ClinVar
PMID:25741868 PMID:34298581
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
G
Scn9a
sodium voltage-gated channel alpha subunit 9
ISO
ClinVar Annotator: match by term: Paroxysmal extreme pain disorder | ClinVar Annotator: match by term: RECTAL PAIN, FAMILIAL CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:15955112 PMID:17145499 PMID:17679678 PMID:18060017 PMID:18414213 PMID:18518989 PMID:18599537 PMID:19369487 PMID:19633428 PMID:19763161 PMID:20038812 PMID:20301342 PMID:20478850 PMID:20635406 PMID:21094958 PMID:21115638 PMID:21698661 PMID:21939494 PMID:22035805 PMID:22136189 PMID:22539570 PMID:22604722 PMID:22826602 PMID:22995991 PMID:23129781 PMID:23232607 PMID:23280954 PMID:23292638 PMID:23450472 PMID:23874707 PMID:23895530 PMID:24033266 PMID:24088041 PMID:24776970 PMID:24817410 PMID:24820863 PMID:24848745 PMID:25250524 PMID:25316021 PMID:25333069 PMID:25741868 PMID:25852444 PMID:25993546 PMID:25995458 PMID:26220970 PMID:26264438 PMID:26284228 PMID:26392352 PMID:26467025 PMID:26633545 PMID:26675522 PMID:26920677 PMID:27301361 PMID:27504264 PMID:27525141 PMID:27608006 PMID:27843123 PMID:27884173 PMID:27956748 PMID:28073787 PMID:28235406 PMID:28440294 PMID:28492532 PMID:29176367 PMID:29264398 PMID:29358611 PMID:29500686 PMID:29653220 PMID:29911575 PMID:29961513 PMID:30316835 PMID:30392441 PMID:30416015 PMID:30478917 PMID:30554136 PMID:30569495 PMID:30642272 PMID:30672368 PMID:30834459 PMID:31193310 PMID:31394368 PMID:31780880 PMID:32601768 PMID:33216760 PMID:37003485 PMID:37079850 PMID:38134749 More...
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
G
Scn8a
sodium voltage-gated channel alpha subunit 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23382806
NCBI chr 7:131,982,152...132,156,075
Ensembl chr 7:131,982,480...132,151,292
G
Scn9a
sodium voltage-gated channel alpha subunit 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23382806
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20627697
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28434951
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Dusp6
dual specificity phosphatase 6
ISO
associated with Inflammation
RGD
PMID:24155322
RGD:7771585
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:plasma
RGD
PMID:9415270
RGD:8547713
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
ISO
RGD
PMID:11984590
RGD:1581700
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
G
Bdnf
brain-derived neurotrophic factor
IMP
RGD
PMID:23313710
RGD:8655857
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Crp
C-reactive protein
ISO
associated with Urolithiasis;
RGD
PMID:20206981
RGD:6909142
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Bloc1s2
biogenesis of lysosomal organelles complex-1, subunit 2
IMP
RGD
PMID:16176350
RGD:2302154
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
G
Tnfrsf1b
TNF receptor superfamily member 1B
treatment
IDA
RGD
PMID:22425187
RGD:7245944
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
F7
coagulation factor VII
ISO
protein:increased activity:plasma (human)
RGD
PMID:17357481
RGD:11049525
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Mir126a
microRNA 126a
ISO
RNA:decreased expression:plasma
RGD
PMID:27900989
RGD:401850572
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Rbp4
retinol binding protein 4
ISO
protein:increased expression:blood serum (human)
RGD
PMID:25142320
RGD:329845867
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
Tlr4
toll-like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18809749
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
G
Adra2a
adrenoceptor alpha 2A
IMP
RGD
PMID:20047711
RGD:6480482
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Bdnf
brain-derived neurotrophic factor
ISO
associated with Colitis; protein:increased expression:dorsal root ganglion:
RGD
PMID:21997550 PMID:19932037
RGD:8655978 , RGD:8657331
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Ephb2
Eph receptor B2
ameliorates
ISO
RGD
PMID:33880135
RGD:127285657
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
G
Gch1
GTP cyclohydrolase 1
treatment
IMP ISO
DNA:haplotype
RGD
PMID:25783971 PMID:25783971
RGD:401700391 , RGD:401700391
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Penk
proenkephalin
treatment
ISO
RGD
PMID:23316929
RGD:10003040
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
IMP
associated with Colitis;
RGD
PMID:23099257
RGD:10043788
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Trpc4
transient receptor potential cation channel, subfamily C, member 4
IMP
RGD
PMID:24388923
RGD:13825245
NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768
G
Trpc4Tn(sb-T2/Bart3)2.192Mcwi
transient receptor potential cation channel, subfamily C, member 4; transposon insertion 2.192, Medical College of Wisconsin
IMP
RGD
PMID:24388923
RGD:13825245
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all